Navigation Links
TargeGen Affiliates Scheduled for Oral Presentation of Interim Clinical Trial Data at 2008 ASH Meeting in San Francisco for TG101348, a Potent, Selective, Oral JAK2 Inhibitor in Myeloproliferative Disease Patients
Date:12/1/2008

SAN DIEGO, Dec. 1 /PRNewswire/ -- TargeGen has announced that an oral presentation of preliminary results from a multi-center, US-based clinical trial of TG101348 in myeloproliferative disease patients has been scheduled at the 2008 American Society of Hematology (ASH) Meeting.

    Details of the presentation are as follows:

    Title:              A Phase I Study of TG101348, an Orally Bioavailable
                        JAK2-Selective Inhibitor, in Patients with
                        Myelofibrosis
    Presenter:          Dr. Animesh Pardanani, Mayo Clinic
    Session Name:       Myeloproliferative Disorders-Experimental Therapeutics
    Session Date:       Sunday, December 7, 2008
    Presentation Time:  4:30 PM
    Room:               Moscone Center SOUTH, Rooms 304-306-308
    Directions:         Howard Street entrance, turn left, up 2 flights of
                        stairs to Esplanade level

About TargeGen, Inc.

TargeGen, Inc. is a privately held vascular biology-focused biopharmaceutical company based in San Diego, CA. TargeGen primarily develops small molecule kinase inhibitors that target vascular leakage (edema), vascular proliferation (angiogenesis) and inflammation. Edema, angiogenesis and inflammation are involved in the pathology of many major human diseases. TargeGen initiated operations in 2002 and has raised capital from top tier venture capital sources. Current investors include VantagePoint Venture Partners, Forward Ventures, Enterprise Partners, Chicago Growth Partners, BB BIOTECH VENTURES, Innovis Investments, H&Q Capital Management, Pappas Ventures, CTI Life Sciences and other investors.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030430/TARGEGENLOGO)


'/>"/>
SOURCE TargeGen, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. TargeGen Announces Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients
2. TargeGen Announces Planned Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients, and Presentations at ASH
3. Starting Flu Vaccination in August Could Help Protect Nearly 11 Million More Children During Scheduled Doctors Visits
4. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
5. Celladon Announces Presentation of Clinical Data From First-in-Human MYDICAR(R) Trial for Advanced Heart Failure at American Heart Association Scientific Sessions
6. Portola Announces Data Presentations Relevant to Its Lead Phase II Antithrombotic Compounds at American Heart Association Scientific Sessions 2008
7. VIA Pharmaceuticals Announces Conference Call and Webcast to Discuss VIA-2291 Phase 2 Data Presentations at AHA
8. Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
9. Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA
10. Cytopia Scientific Presentations on JAK2 Inhibitor Program
11. Paratek to Present Clinical Data in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... & Long, P.A.: , Do you, or did ... , Did you purchase your shares before September 10, ... , Did you lose money in your investment in ... your rights? Rigrodsky & Long, P.A. ... MacFall , announces that a complaint has been filed in the ...
(Date:8/28/2014)... BURLINGTON, Mass. , Aug. 28, 2014 /PRNewswire/ ... imaging system market will grow strongly through 2022 ... 6 percent. This will be largely supported by ... which will increase demand for imaging procedures. The ... also allow more facilities to purchase or upgrade ...
(Date:8/28/2014)... Tianyin Pharmaceutical Co., Inc. (NYSE Amex: ... specializes in patented biopharmaceutical, modernized traditional Chinese medicine ... today updates the timeline for the GMP certification ... The Company is scheduled to submit the ... & Drug Administration,s (CFDA) review in the week ...
Breaking Medicine Technology:Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 2Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 3Indian Diagnostic Imaging System Market Will Grow at 6 Percent Annually Through 2022 2Indian Diagnostic Imaging System Market Will Grow at 6 Percent Annually Through 2022 3TPI Submits Dataset for GMP Inspection at Qionglai Facility (QLF) 2
... Data Presented at the ASCO Cancer Conference, ... 2007 /PRNewswire/,-- The International Myeloma Foundation (IMF)-supporting ... myeloma patients,families, researchers and physicians-today said that ... multi- national clinical trial shows the,combination of ...
... 04, 2007 /PRNewswire/ -- (SEND2PRESS,NEWSWIRE) -- Epeius Biotechnologies ... in medical oncology and a,definitive benchmark in the ... report of its kind, Le Morte du Tumour ... Journal of,Oncology, Vol.30, pp. 1297-1307 -- documents the ...
Cached Medicine Technology:Study Shows Velcade Plus Doxil Improves Survival in Previously,Treated Patients With Multiple Myeloma 2News from the Battlefield of Metastatic Cancer: Epeius,Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G),from the Stone of Chemistry and Physics 2News from the Battlefield of Metastatic Cancer: Epeius,Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G),from the Stone of Chemistry and Physics 3
(Date:8/29/2014)... School of Medicine have identified one way the Ebola ... that could lead to new therapies, in research ... & Microbe . , In work performed at Beamline ... researchers developed a detailed map of how a non-pathogenic ... takes signaling molecules in and out of the cell ...
(Date:8/29/2014)... The 8th Annual Paint Columbus Pink® is a series ... Pooch Contest, Light of Life Ceremony, Power in Prayer, Bright ... – all in support of cancer awareness. , Paint Columbus ... Columbus Pink Foam and Obstacle Challenge on Saturday, October 4th, ... Columbus, Georgia 31904. It will be the first foam and ...
(Date:8/29/2014)... Vancouver, BC (PRWEB) August 29, 2014 ... announced that the company will now be selling purse-sized ... in such a way that they can be carried ... are they portable, the purse-sized range at Honey Gifts ... A long battery life and rechargeable batteries are common ...
(Date:8/29/2014)... FRIDAY, Aug. 29, 2014 (HealthDay News) -- The West African ... World Health Organization announcing an estimated 500 new cases this ... Most of the new cases arose in Liberia, the U.N. ... also rose sharply, the Associated Press reported. ... and control," according to the WHO report. "The situation is ...
(Date:8/29/2014)... September yoga month was created by ... and its health benefits. To support this Ekhart Yoga ... "Yoga Month Challenge" , This 4 week guided online ... experienced yogis practice yoga regularly from their own home. ... ' is suitable for all levels, and the dynamic ...
Breaking Medicine News(10 mins):Health News:Paint Columbus Pink Cancer Awareness/Kick-Off Meeting for Anyone Interested in Participating 2Health News:Honey Gifts Now Provides Purse Sized Adult Toys in Vancouver 2Health News:Biggest Ever Weekly Rise in Ebola Cases, U.N. Agency Says 2Health News:Biggest Ever Weekly Rise in Ebola Cases, U.N. Agency Says 3Health News:Ekhart Yoga Launches the Yoga Month Challenge 2
... fatigue is often a major problem for cancer ... completing therapy. Researchers at Mayo Clinic ( http://www.mayoclinic.org/oncology-rst/ ... ( http://ncctg.mayo.edu/ ) (NCCTG) recently completed a study ... and found that, while it did not improve ...
... M.D., Ph.D., FASTRO, and William McBride, D.Sc., Ph.D., have ... Oncology,s most prestigious award, the Gold Medal. They will ... during ASTRO,s 52nd Annual Meeting, taking place October 31 ... Medal is bestowed on revered members who have made ...
... ... targeted internet traffic to their websites. The solution is all in the PT Marketing Academy. ... to use WordPress blogs, search engine optimization for Google search, Facebook, Twitter, YouTube, and all ... ...
... Montreal, Quebec June 2, 2010 Baby boomers retiring ... in Canada or the U.S., however, a study suggests retirees ... and from the mainstream of Mexican life. The study, ... presented at the 2010 Congress for the Humanities and Social ...
... current problem is the mission of analytical chemistry, according to ... the University of the Basque Country (UPV/EHU). The group,s name ... these problems - Farmartem: the abbreviation in Spanish of pharmaceuticals, ... Art has been the line of research least worked on ...
... after mastectomy fared better, researchers say , WEDNESDAY, June ... after a mastectomy may influence the odds of breast ... the Catholic University of Louvain (Leuven) in Belgium looked ... in 327 women from one to four years after ...
Cached Medicine News:Health News:Results from a study testing methylphenidate for cancer-related fatigue 2Health News:Results from a study testing methylphenidate for cancer-related fatigue 3Health News:Larson, McBride named 2010 ASTRO Gold Medalists 2Health News:New Online Physical Therapy Marketing Academy Helps Physical Therapists Conquer The Web 2Health News:New Online Physical Therapy Marketing Academy Helps Physical Therapists Conquer The Web 3Health News:New Online Physical Therapy Marketing Academy Helps Physical Therapists Conquer The Web 4Health News:New Online Physical Therapy Marketing Academy Helps Physical Therapists Conquer The Web 5Health News:Retirees in Mexico cut off, study says 2Health News:Basque researchers apply chemistry to restoration of paintings and dating of signatures 2Health News:Basque researchers apply chemistry to restoration of paintings and dating of signatures 3
Suction catheter with thumb valve, two eyes, whistle tip...
Rubber bronchial coude catheter, X-ray opaque, one eye, whistle tip....
... 200 Corneal Topographer is the result of ... leader in product innovation and value, continues ... diagnostic instrumentation. The CT 200 is faster ... and repeatable results. The CT 200 is ...
... The patented, accurate and proven DGH-KOI ... the patented MOD III or Neumann ... perfect RK/AK knife. Once a fine ... time-tested quality are then blended to ...
Medicine Products: